Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.68

-2.4%

Dec 12 9:30 AM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Arthur Radley	5/20/2007 6:12:39 PM
	of 52153

NEW YORK, May 20 (Reuters) - Hologic Inc. (HOLX.O: Quote, Profile , Research) on Sunday said it had offered $6.2 billion in cash and stock to buy Cytyc Corp. (CYTC.O: Quote, Profile , Research) in hopes of creating a leading women's health-care company. Hologic and Cytyc, which both make diagnostic and other medical products for women, said the deal is expected to close in the third quarter and will boost Hologic's earnings in the first year afterward and more so in following years. The combined entity would operate in more than 20 countries and have more than 3,300 employees, the companies said in a joint release.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next